These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8410879)

  • 41. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment.
    Goldberg VM; Coutts RD
    Clin Orthop Relat Res; 2004 Feb; (419):130-7. PubMed ID: 15021143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of Systemic Inflammatory Polyarthritis After Zygapophyseal Joint Injection With Hylan G-F 20 (Synvisc-One).
    Kocak D; Annaswamy T; Chong S; Arora R
    Am J Phys Med Rehabil; 2018 Feb; 97(2):147-149. PubMed ID: 28708631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No conclusive evidence that histologically found granulomas and acute local reactions following hylan G-F 20 injections are related or have clinical significance.
    Waddell DD; Beyer A; Thompson TL; Morawiak J; Elkins C; Rosenberg A; Spitzer A
    J Knee Surg; 2014 Apr; 27(2):99-104. PubMed ID: 23873318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Research progress of viscosupplementation].
    Gu Q; Zhou N; Shanghai J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):755-60. PubMed ID: 21735794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the effects of intra-articular injections of Hyaluronan and its chemically cross-linked derivative (Hylan G-F20) in normal rabbit knee joints.
    Schiavinato A; Finesso M; Cortivo R; Abatangelo G
    Clin Exp Rheumatol; 2002; 20(4):445-54. PubMed ID: 12175098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis.
    Migliore A; Giovannangeli F; Granata M; Laganà B
    Clin Med Insights Arthritis Musculoskelet Disord; 2010 Sep; 3():55-68. PubMed ID: 21151854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
    Allard S; O'Regan M
    Clin Ther; 2000 Jun; 22(6):792-5. PubMed ID: 10929925
    [No Abstract]   [Full Text] [Related]  

  • 48. Hyaluronan or hylans for knee osteoarthritis?
    Drug Ther Bull; 1999 Sep; 37(9):71-2. PubMed ID: 10696690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes of synovial fluid protein concentrations in supra-patellar bursitis patients after the injection of different molecular weights of hyaluronic acid.
    Chen CP; Hsu CC; Pei YC; Chen RL; Zhou S; Shen HC; Lin SC; Tsai WC
    Exp Gerontol; 2014 Apr; 52():30-5. PubMed ID: 24487346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synvisc perisynovitis.
    Zardawi IM; Chan I
    Pathology; 2001 Nov; 33(4):519-20. PubMed ID: 11827424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clearance kinetics of a hylan-based viscosupplement after intra-articular and intravenous administration in animal models.
    Larsen NE; Dursema HD; Pollak CT; Skrabut EM
    J Biomed Mater Res B Appl Biomater; 2012 Feb; 100(2):457-62. PubMed ID: 22102374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Musculoskeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle.
    Weiss C; Band P
    Clin Podiatr Med Surg; 1995 Jul; 12(3):497-517. PubMed ID: 7553537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Viscosupplementation for the arthritic ankle.
    Pleimann JH; Davis WH; Cohen BE; Anderson RB
    Foot Ankle Clin; 2002 Sep; 7(3):489-94. PubMed ID: 12512404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The application of shear and extensional viscosity measurements to assess the potential of hylan in viscosupplementation.
    al-Assaf S; Meadows J; Phillips GO; Williams PA
    Biorheology; 1996; 33(4-5):319-32. PubMed ID: 8977658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term experience with hylan GF-20 in the treatment of knee osteoarthritis.
    Conrozier T; Chevalier X
    Expert Opin Pharmacother; 2008 Jul; 9(10):1797-804. PubMed ID: 18570611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain.
    Balazs EA
    Cells Tissues Organs; 2003; 174(1-2):49-62. PubMed ID: 12784041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee : a report of six cases.
    Chen AL; Desai P; Adler EM; Di Cesare PE
    J Bone Joint Surg Am; 2002 Jul; 84(7):1142-7. PubMed ID: 12107313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory and immunological responses to hyaluronan preparations. Study of a murine biocompatibility model.
    Ottaviani RA; Wooley P; Song Z; Markel DC
    J Bone Joint Surg Am; 2007 Jan; 89(1):148-57. PubMed ID: 17200322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intra-articular hyaluronan therapy.
    Marshall KW
    Curr Opin Rheumatol; 2000 Sep; 12(5):468-74. PubMed ID: 10990189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical uses of hyaluronan.
    Balazs EA; Denlinger JL
    Ciba Found Symp; 1989; 143():265-75; discussion 275-80, 281-5. PubMed ID: 2680347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.